NK cell maturation to CD56dim subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

NK cell maturation to CD56dim subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation

Published:2016-04 Issue: Volume:43 Page:58-65
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ghasemzadeh Mehran,Hosseini Ehteramolsadat,Schwarer Anthony P.,Pourfathollah Ali Akbar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. The quest for a bone marrow donor—optimal or maximal HLA matching?;van Rood;N. Engl. J. Med.,1998

2. History of haematopoietic stem-cell transplantation;Little;Nat. Rev. Cancer,2002

3. Immune reconstitution after hematopoietic stem cell transplantation;Thiel,2004

4. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity;Roux;Blood,2000

5. Reconstitution of thymic function after stem cell transplantation in humans;Hakim;Curr. Opin. Hematol.,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease;Human Immunology;2023-04

2. Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms;Journal of Cancer Research and Clinical Oncology;2023-01-12

3. The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia;Stem Cell Reviews and Reports;2022-08-22

4. HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients;Human Immunology;2022-07

5. Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications;Frontiers in Immunology;2022-06-30